How Asymmetric Investing by Travis Hoium’s view on $HIMS changed

2026-09-01Bullish

“The Hims & Hers Australia Strategy: Why It Matters for Investors”

HIMS is a high-growth asymmetric investment case; becoming the global healthcare demand aggregator could increase value 10-100x.

Being a leading telehealth company in the US could be a 10x, maybe even a bigger opportunity for Hims & Hers, but beating being the global telehealth company where you go to answer all your questions no matter where you are in the world is really where the massive opportunity is for healthcare and for Hims & Hers.

Watch the source

2026-08-19Bullish

“4 Incredible Stocks I Love Today”

Hims & Hers is a long-term growth stock with strong potential, supported by reaccelerating revenue growth, subscriber growth, and margin expansion opportunities.

Hims & Hers, as for everything that it has gone through this year, is actually still down almost 20% for the year, but you can see shares bottomed in late February. Since then, up nearly 100% pulled back just a little bit.

They were trading at nearly $40 per share in early July. So, since then, down about 25%. Very volatile stock. So, something to keep in mind for investors.

Watch the source01:43